EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Dietary Modifications in IBS Leads to Reduced Symptoms, Weight, and Lipid Levels: Two Randomized Clinical Trials

Bodil Roth, Bodil Ohlsson iD

Nutrients · 2025

DOI: 10.3390/nu17182966 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Bodil Roth und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Lund University, 22100 Lund, Sweden. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Lipids, Weight Loss, Diet, Reducing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Development Foundation of Region Skåne, Foundation of Skåne University Hospital, Dir Albert Påhlsson´s Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Irritable bowel syndrome (IBS) is presented with both gastrointestinal and extraintestinal symptoms. In addition, overweight/obesity and metabolic syndrome is prevalent in IBS. Dietary interventions with a low content of fermentable oligo-, di-, and monosaccharides and polyols (FODMAP) or a starch- and sucrose-reduced diet (SSRD) efficiently reduce symptoms and weight. Our hypothesis was that not only nutrition composition but also weight reduction is of importance for symptom relief. The aim was to merge two randomized trials and examine symptoms, weight, nutrition intake, and lipid levels at baseline and during nutritional intervention.

Methods

One study with 105 IBS patients randomized to either an SSRD (n = 80) or control diet (n = 25) and one study with 155 IBS patients randomized to an SSRD (n = 77) or low FODMAP (n = 78) were merged. Symptom and food questionnaires were analyzed together with weight/body mass index (BMI) and lipid levels.

Results

Patients had moderate or severe IBS at baseline, and half of them were overweight/obese. Energy intake was reduced by both diets, with the most pronounced carbohydrate reduction after the SSRD. The cholesterol levels were highest in the second cohort, possibly due to the higher fat and lower starch intake. About 25% had high-density lipoprotein below reference levels. Gastrointestinal and extraintestinal symptoms, as well as weight/BMI, were reduced by the SSRD and low FODMAP, but not in the control group. The SSRD in the second cohort and low FODMAP rendered lower levels of total cholesterol, low-density lipoprotein, and non-high-density lipoprotein levels. Weight/BMI were more often associated with lipid levels and symptoms than nutrient composition at baseline, and weight/BMI reductions correlated with carbohydrate reduction and were associated with a reduction in gastrointestinal and extraintestinal symptoms.

Conclusions

Not only food components, but also overweight/obesity may be of importance for the development and severity of IBS and related symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromeLipidsWeight LossDiet, ReducingHumansMaleFemaleAdultMiddle AgedObesityBody Mass IndexOverweightEnergy IntakeBody WeightMonosaccharidesDietary CarbohydratesPolymers

Stichwörter der Autor:innen

SSRDdietary habitsirritable bowel syndromelipid profilelow FODMAPsymptomsweight

Substanzen

LipidsMonosaccharidespolyolDietary CarbohydratesPolymers

Autor:innen und Institutionen

  • Department of Clinical Sciences, Lund University, 22100 Lund, Sweden.
  • Department of Internal Medicine, Skåne University Hospital, 20502 Malmö, Sweden.

ORCID-Profile: Bodil Ohlsson

Förderung

  • Development Foundation of Region Skåne
  • Foundation of Skåne University Hospital
  • Dir Albert Påhlsson´s Foundation
  • Dir Albert Påhlsson’s Foundation (BO)

Zitieren

APA

Roth, B., & Ohlsson, B. (2025). Dietary Modifications in IBS Leads to Reduced Symptoms, Weight, and Lipid Levels: Two Randomized Clinical Trials. Nutrients. https://doi.org/10.3390/nu17182966

Vancouver

Roth B, Ohlsson B. Dietary Modifications in IBS Leads to Reduced Symptoms, Weight, and Lipid Levels: Two Randomized Clinical Trials. Nutrients. 2025. doi:10.3390/nu17182966

BibTeX
@article{Roth2025,
  author = {Roth, Bodil and Ohlsson, Bodil},
  title = {Dietary Modifications in IBS Leads to Reduced Symptoms, Weight, and Lipid Levels: Two Randomized Clinical Trials},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17182966}
}
Kostenlos starten →